益佰制药: 贵州益佰制药股份有限公司2025年第一次临时股东大会决议公告

Meeting Overview - The shareholder meeting of Guizhou Yibai Pharmaceutical Co., Ltd. was held on September 5, 2025, at the company's administrative building meeting room [1] - The meeting was chaired by the chairman, Ms. Dou Qiling, and utilized a combination of on-site and online voting methods, complying with the Company Law and the company's articles of association [1] Voting Results - All proposed resolutions were passed with significant majority votes, with A-shareholders showing high approval rates ranging from 98.1052% to 98.6529% across various resolutions [2][3] - Specific voting results included: - 193,042,393 votes in favor (98.5460%), 2,681,326 against (1.3687%), and 166,900 abstentions (0.0853%) for one resolution [1] - 192,934,793 votes in favor (98.4910%), 2,760,626 against (1.4092%), and 195,200 abstentions (0.0998%) for another resolution [2] Legal Compliance - The meeting's procedures were confirmed to be in accordance with the Company Law, Shareholder Meeting Rules, and other relevant legal documents, ensuring the legitimacy of the resolutions passed [3]